Does XTANDI Cause Prostatic specific antigen increased? 94 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Prostatic specific antigen increased have been filed in association with XTANDI. This represents 6.8% of all adverse event reports for XTANDI.
94
Reports of Prostatic specific antigen increased with XTANDI
6.8%
of all XTANDI reports
5
Deaths
7
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From XTANDI?
Of the 94 reports, 5 (5.3%) resulted in death, 7 (7.4%) required hospitalization.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XTANDI. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does XTANDI Cause?
Malignant neoplasm progression (235)
Death (234)
Fatigue (162)
Drug ineffective (158)
Nausea (69)
Asthenia (62)
Decreased appetite (56)
Dizziness (52)
Diarrhoea (51)
Back pain (41)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)